drugset / Trial / NCT00720278
A Study to Evaluate the Safety and Efficacy of Two Nasal Sprays to Treat Seasonal Allergies
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study was to determine if two allergy medications are more effective than placebo.
Timeline
- Start
- 2007-08
- Primary completion
- 2007-10
- Completion
- 2007-11
Outcome
Met primary endpoint
registry analysis (superiority or other test); Placebo vs Astepro 0.1%; p <0.001; Mean Difference (Final Values) -2.06 (95% CI -2.98 to -1.14); ANCOVA NCT00720278 ↗
registry analysis (superiority or other test); Placebo vs Astepro 0.15%; p <0.001; Mean Difference (Final Values) -3.00 (95% CI -3.91 to -2.09); ANCOVA NCT00720278 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azelastine | Small molecule | 1096 ug | Intranasal |
| Subject | Azelastine | Small molecule | 1644 ug | Intranasal |